Recently, case-control genome wide association studies suggest rare pathogenic variants in the SRY-related HMG-box (SOX17) gene, increase PAH risk, in addition to common variants upstream of the gene promoter2–4. The gene discussed is SOX17; the disease is pulmonary arterial hypertension.